Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacopo Monticelli

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Jac-Antimicrobial Resistance|May 7, 2025
Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing <i>Klebsiella pneumoniae</i> otomastoiditisStella Babich, Pier Giorgio Cojutti, Milo Gatti, et al.
International Journal of Molecular Sciences|February 10, 2024
Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell LinesValentina Zanrè, Francesco Bellinato, Alessia Cardile, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|August 18, 2020
Therapeutic Options for Infections due to vanB Genotype Vancomycin-Resistant EnterococciNiccolò Riccardi, Jacopo Monticelli, Roberta Maria Antonello, et al.
Clinical Microbiology Reviews|February 29, 2024
<i>Clostridioides difficile</i> infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future optionsStefano Di Bella, Gianfranco Sanson, Jacopo Monticelli, et al.
HIV Clinical Trials|August 9, 2013
Sustained virological response and baseline predictors in HIV-HCV coinfected patients retreated with pegylated interferon and ribavirin after failing a previous interferon-based therapy: systematic review and meta-analysisMonica Basso, Saverio Giuseppe Parisi, Carlo Mengoli, et al.
Annali Dell'Istituto Superiore Di Sanita|September 22, 2020
Schiavonia Hospital response to COVID-19 outbreak: a first single-center experienceElena Marcon, Francesca Scotton, Elena Marcante, et al.
Infection|March 8, 2017
Correlation between antibiotic consumption and resistance of bloodstream bacteria in a University Hospital in North Eastern Italy, 2008-2014Marta Mascarello, Omar Simonetti, Anna Knezevich, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 18, 2019
Mycobacterium chimaera infections: An updateNiccolò Riccardi, Jacopo Monticelli, Roberta Maria Antonello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2026
When and How to Use Subcutaneous AntibioticsStefano Di Bella, Nicholas Geremia, Federico Pea, et al.
Antibiotics (Basel, Switzerland)|July 27, 2024
Risk Factors for 30-Day Mortality in Nosocomial Enterococcal Bloodstream InfectionsVerena Zerbato, Riccardo Pol, Gianfranco Sanson, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Jac-Antimicrobial Resistance|May 7, 2025
Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing <i>Klebsiella pneumoniae</i> otomastoiditisStella Babich, Pier Giorgio Cojutti, Milo Gatti, et al.
International Journal of Molecular Sciences|February 10, 2024
Lamivudine, Doravirine, and Cabotegravir Downregulate the Expression of Human Endogenous Retroviruses (HERVs), Inhibit Cell Growth, and Reduce Invasive Capability in Melanoma Cell LinesValentina Zanrè, Francesco Bellinato, Alessia Cardile, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|August 18, 2020
Therapeutic Options for Infections due to vanB Genotype Vancomycin-Resistant EnterococciNiccolò Riccardi, Jacopo Monticelli, Roberta Maria Antonello, et al.
Clinical Microbiology Reviews|February 29, 2024
<i>Clostridioides difficile</i> infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future optionsStefano Di Bella, Gianfranco Sanson, Jacopo Monticelli, et al.
HIV Clinical Trials|August 9, 2013
Sustained virological response and baseline predictors in HIV-HCV coinfected patients retreated with pegylated interferon and ribavirin after failing a previous interferon-based therapy: systematic review and meta-analysisMonica Basso, Saverio Giuseppe Parisi, Carlo Mengoli, et al.
Annali Dell'Istituto Superiore Di Sanita|September 22, 2020
Schiavonia Hospital response to COVID-19 outbreak: a first single-center experienceElena Marcon, Francesca Scotton, Elena Marcante, et al.
Infection|March 8, 2017
Correlation between antibiotic consumption and resistance of bloodstream bacteria in a University Hospital in North Eastern Italy, 2008-2014Marta Mascarello, Omar Simonetti, Anna Knezevich, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 18, 2019
Mycobacterium chimaera infections: An updateNiccolò Riccardi, Jacopo Monticelli, Roberta Maria Antonello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2026
When and How to Use Subcutaneous AntibioticsStefano Di Bella, Nicholas Geremia, Federico Pea, et al.
Antibiotics (Basel, Switzerland)|July 27, 2024
Risk Factors for 30-Day Mortality in Nosocomial Enterococcal Bloodstream InfectionsVerena Zerbato, Riccardo Pol, Gianfranco Sanson, et al.
Pageof 3